Home Tags Semma Therapeutics

Tag: Semma Therapeutics

Thorne Sparkman joined Slater in 2000 as executive director of what was then known as the Slater Center for Interactive Technologies. He focuses on the earliest stage of company creation, including working with university-based teams commercializing research. / PBN PHOTO/RUPERT WHITELEY

Support the founders

Thorne Sparkman | Slater Technology Fund managing director As a seed-stage investor, I spend countless hours discovering and courting entrepreneurs, because the founders of today’s...
VERTEX HAS entered into an agreement to purchase Semma Therapeutics for $950 million in cash.

Vertex to acquire Semma Therapeutics

PROVIDENCE – Vertex Pharmaceuticals Inc. has entered into an agreement to acquire Semma Therapeutics for $950 million in cash, the companies announced Tuesday. Both companies...
SEMMA THERAPEUTICS, a Massachusetts biotechnology company with ties to Providence, successfully raised millions of dollars to advance its work in the field of cell therapy to treat individuals with diabetes. / COURTESY SEMMA PHARMACEUTICAL

Semma Therapeutics raises $114M in Series B funding round

PROVIDENCE – Semma Therapeutics, a Massachusetts biotechnology company with ties to Providence, recently raised $114 million in an equity financing round. The company, based in...
THE PROP: Briannan Bintz’s work at Semma Therapeutics is designed to ­allow people to better control diabetes through microencapsulation devices.

Briannan Bintz, 36 Director of encapsulation research — Semma Therapeutics

Where do you see yourself professionally in 20 years? I don’t think I would change much. I’d still like to be working on cutting-edge research...

Stay up to date with PBN's Morning Call & Daily Edition newsletters.

- Featured Event -

Latest News

Get Award-Winning Journalism: Unlimited access to PBN
Digital + Print for just $1.90 per week.

(with annual subscription)